Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.
Stacchiotti S, Martini S, Pasquali S, Frezza AM, Beretta A, Percio S, Lecchi M, Tortoreto M, Barisella M, Collini P, Dagrada GP, Merlini A, Huang PH, Jenks A, Jones RL, Tap WD, Ingrosso M, Morosi C, Brich S, Giani C, Verderio P, Casali PG, Leonard H, Gronchi A, Zuco V, Zaffaroni N. Stacchiotti S, et al. Among authors: frezza am. Clin Cancer Res. 2024 Nov 15;30(22):5122-5137. doi: 10.1158/1078-0432.CCR-23-3991. Clin Cancer Res. 2024. PMID: 39283723 Free PMC article.
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy.
Fernanda Amary M, Ye H, Berisha F, Khatri B, Forbes G, Lehovsky K, Frezza AM, Behjati S, Tarpey P, Pillay N, Campbell PJ, Tirabosco R, Presneau N, Strauss SJ, Flanagan AM. Fernanda Amary M, et al. Among authors: frezza am. Cancer Med. 2014 Aug;3(4):980-7. doi: 10.1002/cam4.268. Epub 2014 May 27. Cancer Med. 2014. PMID: 24861215 Free PMC article.
Bone metastases from neuroendocrine neoplasms: Results of an Italian nationwide survey of natural history and management.
Fazio N, Maisonneuve P, Frezza AM, Ranallo N, Ibrahim T, La Salvia A, Brizzi MP, De Divitiis C, Tafuto S, Pusceddu S, Marconcini R, Cives M, Ferrari C, Campana D, De Lisi D, Santini D, Faggiano A, Modica R, Massironi S, Bianchi A, Panzuto F, Antonuzzo L, Pellegrini E, Amoroso V, Puliafito I, Merola E, Silvestris N, Grana CM, Spada F. Fazio N, et al. Among authors: frezza am. J Neuroendocrinol. 2025 Nov 18:e70115. doi: 10.1111/jne.70115. Online ahead of print. J Neuroendocrinol. 2025. PMID: 41255062
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.
D'Ambrosio L, Sbaraglia M, Merlini A, Rabino M, Grignani G, Appolloni V, Badalamenti G, Baldi GG, Bellan E, Benelli M, Bertuzzi AF, Biagini R, Bianchi G, Boglione A, Brunello A, Campanacci DA, Cananzi F, Casali PG, Casini B, Cesari M, Chiusole B, Cristalli C, De Vita A, Di Blasi E, Fagioli F, Fausti V, Ferraresi V, Frezza AM, Fumagalli E, Gambarotti M, Giani C, Gronchi A, Grassi M, Ibrahim T, Ivanescu A, Ignazzi G, Incorvaia L, Linari A, Luksch R, Marrari A, Mazzocca A, Milano GM, Morosi C, Nannini M, Navarria P, Palassini E, Palmerini E, Paloschi F, Pantaleo MA, Pasquali S, Pavese V, Pozzo E, Quagliuolo V, Quirino M, Sanfilippo R, Santoro F, Scotlandi K, Serra M, Setola E, Strippoli S, Tafuto S, Tirtei E, Vanni S, Vincenzi B, Maestro R, Dei Tos AP, Stacchiotti S. D'Ambrosio L, et al. Among authors: frezza am. Crit Rev Oncol Hematol. 2025 Dec;216:104960. doi: 10.1016/j.critrevonc.2025.104960. Epub 2025 Sep 23. Crit Rev Oncol Hematol. 2025. PMID: 40998028 Free article. Review.
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Stacchiotti S, Pantziarka P, Leonard H, Voltz C, Abatedaga L, Bouche G, Bouygues C, Bovee JVMG, Van der Graaf WTA, Rojas T, D'Ambrosio L, Donoghue M, Enzmann H, Feeney G, Foggi P, Frezza AM, Herold R, Jones RL, Kasper B, Roes K, Marreaud S, Miceli R, Robinson D, Sommer J, Tap WD, Tydings C, Trama A, Houdt WV, van Oortmerssen G, Wagner AJ, Widemann B, Gelderblom H, Gronchi A, Napolitano A, Dufresne A, Fumagalli ER, Baldi G, Marquina G, Koseła-Paterczyk H, Martin Javier JB, Junker N, Rutkowski P, Oyen WJG, Lacombe D, Pignatti F, Demolis P. Stacchiotti S, et al. Among authors: frezza am. Cancer Treat Rev. 2025 Nov;140:103003. doi: 10.1016/j.ctrv.2025.103003. Epub 2025 Aug 6. Cancer Treat Rev. 2025. PMID: 40789252 Review.
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).
Callegaro D, Tinè G, Oppong FB, Nzokirantevye A, Litière S, Percio S, Carenzo A, De Cecco L, Chibon F, Brich S, Bertolotti A, Collini P, Frezza AM, Huang P, Haas R, Bonvalot S, van Houdt WJ, Miceli R, Pasquali S, Gronchi A. Callegaro D, et al. Among authors: frezza am. Clin Cancer Res. 2025 Aug 1;31(15):3239-3248. doi: 10.1158/1078-0432.CCR-25-0099. Clin Cancer Res. 2025. PMID: 40423526 Free PMC article.
Proximal and Classic Epithelioid Sarcomas are Distinct Molecular Entities Defined by MYC/GATA3 and SOX17/Endothelial Markers, Respectively.
Sigalotti L, Frezza AM, Sbaraglia M, Del Savio E, Baldazzi D, Valenti B, Bellan E, De Benedictis I, Doni M, Gambarotti M, Vincenzi B, Brunello A, Baldi GG, Palmerini E, Pasquali S, Ciuffetti ME, Varano V, Cappello F, Appolloni V, Pastrello C, Jurisica I, Gronchi A, Stacchiotti S, Casali PG, Dei Tos AP, Maestro R. Sigalotti L, et al. Among authors: frezza am. Mod Pathol. 2025 Jan;38(1):100647. doi: 10.1016/j.modpat.2024.100647. Epub 2024 Nov 2. Mod Pathol. 2025. PMID: 39491746 Free article.
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.
Frezza AM, Leonard H, Aggerholm-Pedersen N, Badalamenti G, Baili P, Baldi GG, Bauer S, Bazzurri S, Benzonelli I, Bertuzzi A, Blay JY, Bianchi G, Bonfarnuzzo S, Bouvier C, Boye K, Martin Broto J, Brunello A, Campanacci D, Casali PG, Cicala C, Crotti E, D'Ambrosio L, Dei Tos AP, Dieckmann N, Dufresne A, Elston S, Ferraresi V, Gabellini S, Giani C, Giannusa V, Gil Sanjines M, Grassani T, Gronchi A, Lasalvia P, Lindskog S, Hindi N, Ingrosso M, Ivanescu A, Jones R, Lugowska I, Ketzer J, Mariuk-Jarema A, Mazzocca A, Monteleone L, Morosi C, Napolitano A, Nardozza F, Neri E, Nilsson M, Papakonstantinou A, Pasquali S, Sbaraglia M, Scolari F, Szkandera J, Valverde C, Vincenzi B, Vizzaccaro S, Zuccheri F, Stacchiotti S, Trama A. Frezza AM, et al. PLoS One. 2024 Aug 12;19(8):e0308387. doi: 10.1371/journal.pone.0308387. eCollection 2024. PLoS One. 2024. PMID: 39133752 Free PMC article.
Current Management of Desmoid Tumors: A Review.
Kasper B, Baldini EH, Bonvalot S, Callegaro D, Cardona K, Colombo C, Corradini N, Crago AM, Dei Tos AP, Dileo P, Elnekave E, Erinjeri JP, Navid F, Farma JM, Ferrari A, Fiore M, Gladdy RA, Gounder M, Haas RL, Husson O, Kurtz JE, Lazar AJ, Orbach D, Penel N, Ratan R, Raut CP, Roland CL, Schut AW, Sparber-Sauer M, Strauss DC, Van der Graaf WTA, Vitellaro M, Weiss AR, Gronchi A; Desmoid Tumor Working Group. Kasper B, et al. JAMA Oncol. 2024 Aug 1;10(8):1121-1128. doi: 10.1001/jamaoncol.2024.1805. JAMA Oncol. 2024. PMID: 38900421 Review.
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis.
Palassini E, Baldi GG, Ciniselli CM, Gennaro M, Gronchi A, Sangalli C, Conforti F, Collini P, Frezza AM, Pellegrini I, Allajbej A, Fiore M, Morosi C, Pennacchioli E, Barisella M, Casali PG, Verderio P, De Pas T, Stacchiotti S. Palassini E, et al. Among authors: frezza am. ESMO Open. 2024 Jun;9(6):103474. doi: 10.1016/j.esmoop.2024.103474. Epub 2024 Jun 3. ESMO Open. 2024. PMID: 38833974 Free PMC article.
97 results